Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Bevirimat> ?p ?o. }
Showing items 1 to 66 of
66
with 100 items per page.
- Bevirimat abstract "Bevirimat (research code MPC-4326) is an anti-HIV drug derived from a betulinic acid-like compound, first isolated from Syzygium claviflorum, a Chinese herb. It is believed to inhibit HIV by a novel mechanism, so-called maturation inhibition. It is not currently U.S. Food and Drug Administration (FDA) approved. It was originally developed by the pharmaceutical company Panacos and reached Phase IIb clinical trials. Myriad Genetics announced on January 21, 2009 the acquisition of all rights to bevirimat for $7M USD. On June 8, 2010 Myriad Genetics announced that it was halting the development of maturation inhibitors, including bevirimat, to focus more on their oncology portfolio.".
- Bevirimat atcPrefix "none".
- Bevirimat casNumber "174022-42-5".
- Bevirimat fdaUniiCode "S125DW66N8".
- Bevirimat iupacName "3β- (3-carboxy-3-methyl -butanoyloxy) lup-20(29)- en-28-oic acid".
- Bevirimat pubchem "457928".
- Bevirimat thumbnail Bevirimat.svg?width=300.
- Bevirimat wikiPageExternalLink bevirimat_1897.shtml.
- Bevirimat wikiPageExternalLink panacosmovie.html.
- Bevirimat wikiPageExternalLink product_2.htm.
- Bevirimat wikiPageID "14550347".
- Bevirimat wikiPageRevisionID "590762076".
- Bevirimat atcPrefix "none".
- Bevirimat c "36".
- Bevirimat casNumber "174022".
- Bevirimat chembl "404519".
- Bevirimat chemspiderid "403003".
- Bevirimat eliminationHalfLife "250200.0".
- Bevirimat excretion "fecal".
- Bevirimat h "56".
- Bevirimat hasPhotoCollection Bevirimat.
- Bevirimat iupacName "3".
- Bevirimat metabolism "Hepatic glucuronidation".
- Bevirimat molecularWeight "584.826".
- Bevirimat niaidChemdb "28530".
- Bevirimat o "6".
- Bevirimat pubchem "457928".
- Bevirimat routesOfAdministration "Oral".
- Bevirimat smiles "CCC1CCC2CO".
- Bevirimat stdinchi "1".
- Bevirimat stdinchikey "YJEJKUQEXFSVCJ-WRFMNRASSA-N".
- Bevirimat synonyms "PA-457, 3-O-- betulinic acid".
- Bevirimat unii "S125DW66N8".
- Bevirimat verifiedfields "changed".
- Bevirimat verifiedrevid "459978178".
- Bevirimat subject Category:Carboxylic_acids.
- Bevirimat subject Category:Maturation_inhibitors.
- Bevirimat subject Category:Triterpenes.
- Bevirimat type Abstraction100002137.
- Bevirimat type Acid114607521.
- Bevirimat type CarboxylicAcid114739360.
- Bevirimat type CarboxylicAcids.
- Bevirimat type Chemical114806838.
- Bevirimat type Compound114818238.
- Bevirimat type Material114580897.
- Bevirimat type Matter100020827.
- Bevirimat type Part113809207.
- Bevirimat type PhysicalEntity100001930.
- Bevirimat type Relation100031921.
- Bevirimat type Substance100019613.
- Bevirimat type Drug.
- Bevirimat type DrugProduct.
- Bevirimat type FunctionalSubstance.
- Bevirimat comment "Bevirimat (research code MPC-4326) is an anti-HIV drug derived from a betulinic acid-like compound, first isolated from Syzygium claviflorum, a Chinese herb. It is believed to inhibit HIV by a novel mechanism, so-called maturation inhibition. It is not currently U.S. Food and Drug Administration (FDA) approved. It was originally developed by the pharmaceutical company Panacos and reached Phase IIb clinical trials.".
- Bevirimat label "Bevirimat".
- Bevirimat label "Bevirimat".
- Bevirimat label "Bevirimat".
- Bevirimat sameAs Bevirimat.
- Bevirimat sameAs Bevirimat.
- Bevirimat sameAs m.03d7lmk.
- Bevirimat sameAs Q851897.
- Bevirimat sameAs Q851897.
- Bevirimat sameAs Bevirimat.
- Bevirimat wasDerivedFrom Bevirimat?oldid=590762076.
- Bevirimat depiction Bevirimat.svg.
- Bevirimat isPrimaryTopicOf Bevirimat.
